Physician profile
Susan S Rice
NPI 1205909330
$1,040.34
in general payments reported to CMS, 2019-2025
24 companies · $98.03 in 2025
The $98.03 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $143 · 2023: $132 · 2024: $311 · 2025: $98.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.89 | 2021-2024 | |
| Pfizer INC. | $154.90 | 2021 | |
| Acadia Pharmaceuticals INC | $124.78 | 2024 | Nuplazid |
| Vanda Pharmaceuticals INC. | $49.96 | 2024-2025 | Fanapt |
| Regeneron Healthcare Solutions, INC. | $47.49 | 2023 | Evkeeza |
| Krystal Biotech INC | $34.99 | 2024-2025 | Vyjuvek |
| Glaxosmithkline, LLC. | $33.82 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.34 | 2021 | |
| Medtronic, INC. | $27.45 | 2025 | Minimed 780g |
| Astrazeneca Pharmaceuticals LP | $25.68 | 2021-2022 | |
| Lilly USA, LLC | $24.97 | 2022-2023 | Mounjaro |
| Ultragenyx Pharmaceutical INC. | $21.81 | 2023 | |
| Abbott Laboratories | $21.38 | 2022 | |
| Dexcom, INC. | $19.19 | 2021 | |
| Amarin Pharma, INC. | $18.12 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.85 | 2025 | Wegovy |
| Corcept Therapeutics | $16.64 | 2024 | Korlym |
| Janssen Pharmaceuticals, INC | $16.45 | 2021 | |
| Supernus Pharmaceuticals, INC. | $16.11 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.05 | 2024 | Voquezna |
| Sunovion Pharmaceuticals INC. | $14.88 | 2022 | |
| Qol Medical, LLC | $14.53 | 2023 | Sucraid |
| Inspire Medical Systems, INC. | $14.40 | 2025 | Inspire |
| Nevro Corp. | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.